IRIS
TISONE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 86.203
AS - Asia 11.418
EU - Europa 7.873
SA - Sud America 1.615
Continente sconosciuto - Info sul continente non disponibili 944
AF - Africa 149
OC - Oceania 19
Totale 108.221
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 85.754
SG - Singapore 5.533
CN - Cina 2.232
BR - Brasile 1.287
RU - Federazione Russa 1.273
IT - Italia 1.223
HK - Hong Kong 1.168
UA - Ucraina 1.074
DE - Germania 1.050
VN - Vietnam 829
IE - Irlanda 816
FI - Finlandia 660
GB - Regno Unito 492
SE - Svezia 379
BD - Bangladesh 340
FR - Francia 337
KR - Corea 296
JP - Giappone 290
CA - Canada 231
IN - India 201
NL - Olanda 132
AR - Argentina 112
PL - Polonia 105
TR - Turchia 81
ID - Indonesia 80
AT - Austria 73
MX - Messico 73
ES - Italia 66
IQ - Iraq 57
CO - Colombia 55
EC - Ecuador 52
ZA - Sudafrica 48
BE - Belgio 36
JM - Giamaica 34
CL - Cile 30
CZ - Repubblica Ceca 29
MY - Malesia 27
SA - Arabia Saudita 26
VE - Venezuela 26
EG - Egitto 22
PK - Pakistan 22
CR - Costa Rica 20
PY - Paraguay 20
UZ - Uzbekistan 20
PH - Filippine 19
TH - Thailandia 19
TT - Trinidad e Tobago 19
AU - Australia 18
CH - Svizzera 18
AE - Emirati Arabi Uniti 17
IL - Israele 16
GR - Grecia 15
HN - Honduras 14
JO - Giordania 14
KE - Kenya 14
RO - Romania 14
AZ - Azerbaigian 13
EU - Europa 13
KZ - Kazakistan 13
MA - Marocco 13
NP - Nepal 13
UY - Uruguay 13
KG - Kirghizistan 12
TN - Tunisia 12
DZ - Algeria 11
IR - Iran 11
NI - Nicaragua 11
PE - Perù 11
LT - Lituania 10
MD - Moldavia 10
DO - Repubblica Dominicana 9
OM - Oman 8
BO - Bolivia 7
GT - Guatemala 7
LB - Libano 7
NG - Nigeria 7
NO - Norvegia 6
PS - Palestinian Territory 6
PT - Portogallo 6
AM - Armenia 5
BG - Bulgaria 5
SN - Senegal 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
AG - Antigua e Barbuda 4
AL - Albania 4
BS - Bahamas 4
EE - Estonia 4
HR - Croazia 4
HU - Ungheria 4
KH - Cambogia 4
KW - Kuwait 4
LV - Lettonia 4
MN - Mongolia 4
MT - Malta 4
PR - Porto Rico 4
TM - Turkmenistan 4
A1 - Anonimo 3
A2 - ???statistics.table.value.countryCode.A2??? 3
Totale 107.225
Salva come PNG Salva come JPEG
Città #
Woodbridge 22.646
Wilmington 21.025
Houston 18.742
Singapore 2.732
Fairfield 2.213
Ashburn 1.954
Ann Arbor 1.942
San Jose 1.543
Chandler 1.156
Hong Kong 1.144
Jacksonville 976
Seattle 970
New York 858
Cambridge 826
Beijing 824
Dublin 800
Medford 597
Santa Clara 517
Council Bluffs 508
Helsinki 409
The Dalles 392
Los Angeles 359
Rome 344
Dearborn 332
Zhengzhou 283
Lawrence 280
Ho Chi Minh City 264
Tokyo 233
Buffalo 230
Moscow 220
Hanoi 184
Mülheim 172
San Diego 147
São Paulo 143
Dallas 130
Milan 128
Lauterbourg 126
Boardman 118
Denver 111
Chicago 109
Orem 105
Menlo Park 95
Elk Grove Village 93
Sunnyvale 89
Hangzhou 87
Atlanta 82
Munich 75
London 73
Shanghai 71
North Bergen 69
Montreal 68
Frankfurt am Main 65
Phoenix 65
Chennai 64
Jersey City 61
Nuremberg 59
San Mateo 55
Brooklyn 53
Creede 51
Warsaw 51
Redwood City 50
Guangzhou 49
University Park 49
Manchester 47
Palo Alto 46
Toronto 45
Mountain View 44
Rio de Janeiro 44
Amsterdam 43
Jakarta 42
Verona 42
Nanjing 41
San Francisco 40
Falls Church 39
Saint Petersburg 39
Johannesburg 38
Norwalk 38
Redondo Beach 36
Stockholm 36
Washington 36
Columbus 35
Poplar 35
Hefei 33
Vienna 32
Belo Horizonte 30
Da Nang 30
Kraków 30
Seoul 30
Brussels 28
Lappeenranta 28
Miami 28
Brasília 27
Engelhard 27
Haiphong 26
Salt Lake City 26
Detroit 25
Mexico City 25
Kunming 24
Mumbai 24
Turin 24
Totale 89.529
Salva come PNG Salva come JPEG
Nome #
Hepatitis C reinfection after liver transplantation in relation to virus genotype 625
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence 603
Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression 597
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 592
Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study 566
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 547
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 537
Re-Evaluation of the Role of Antifibrinolytic Therapy with Lysine Analogs in Liver Transplantation in The Post-Aprotinin Era 524
Recurrence of insulin resistant metabolic syndrome following liver transplantation 522
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. 519
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. 519
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization 512
Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans 511
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 510
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 510
Graft failure due to hemolytic uremic syndrome recurrence 507
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 505
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 501
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 500
Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques. 499
Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo. 497
Operational tolerance in clinical liver transplantation: emerging developments. 497
Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft 494
Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft. 494
Use of mycophenolate mofetil in liver transplantation: a literature review. 494
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 493
Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers 488
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 486
Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. 484
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 483
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 483
Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease 482
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 482
Marginal donors in liver transplantation. 481
Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders 478
Infectious complications in renal transplant recipients 478
Conversion to rapamycin immunosuppression for malignancy after kidney transplantation 478
10-28 year follow-up in 23 patients with kideny traansplantation: immunosuppressive therapy, survival and complications 475
596 474
Leptin attenuates ischemia-reperfusion injury in the rat liver. 473
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 473
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation 472
Interposition of the right colic angle between the liver and thoracic wall: an unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient. 468
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 467
Is nephrectomy indicated in uremic patients with ADPKD waiting for transplant? 465
Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: a biochemical and ultra-structural study in humans 464
Clinical and neurophysiological evidence of polyneuropathy in liver transplant candidates: preliminary report. 464
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension 463
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 459
Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases. 458
Graft failure due to hemolytic uremic syndrome recurrence 458
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study 458
A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: With or without steroids? 458
Ureteral obstruction in 140 renal transplant patients: preventions and treatment 457
Liver abscess caused by foreign body ingestion 456
Management of spermatic cord liposarcoma in renal transplant recipients: case report 455
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. 454
Phase I clinical trial with the AMC-bioartificial liver. 454
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 454
Multiparameter immune profiling of operational tolerance in liver transplantation. 453
Quality of life and long-term follow-up after kidney transplantation: a 30-year clinical study. 453
Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation. 451
Flow cytometric analysis of antidonor-specific antibodies in liver transplant. 450
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 450
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 450
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. 448
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 448
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids 448
TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKC alpha-ezrin pathway 448
Reduced acute rejection and side effects with neoral in liver transplantation. 447
Sequential changes in serum and biliary bile acids after liver transplantation 446
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 446
Interposition of the right colic angle between the liver and thoracic wall: An unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient 445
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation 445
Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient: a case report. 445
Average results and follow-up in 11 over-60 years of age kidney transplanted patients 443
Raised hematocrit--a contributing factor to hepatic artery thrombosis following liver transplantation. 443
Immunosuppression-Free Liver Transplantation 443
Split-liver transplantation with pediatric donors: a multicenter experience. 442
Liver transplantation for end-stage liver disease related to viral hepatitis 442
Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins 442
Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients 441
Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. 441
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C 439
Gravity perfusion versus high-pressure perfusion in kidney transplantation: results from a prospective randomized study. 439
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation 439
Immunosuppression without prednisone after liver transplantion is safe and associated with normal early graft function: preliminary results of a randomized study 438
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 438
Surgical versus percutaneous technique for veno-venous bypass during orthotopic liver transplantation: a prospective randomized study. 437
Clinical Significance of de novo production of HLA of donor-specific antibodies in kidney transplantation. 437
Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation. 437
Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. 435
Spontaneous resolution of severe acute rejection in liver transplantation. 434
Liver transplantation in the presence of portal vein thrombosis: report from a single center. 434
2.0 J Ti:sapphire laser oscillator. 434
Characterization of γδ T cell subsets in organ transplantation. 433
[An unusual case of ureteral obstruction after kidney transplantation]. 433
Liver transplantation for the treatment of nodular regenerative hyperplasia 431
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 431
Spontaneous resolution of severe acute rejection in liver transplantation 430
Totale 47.266
Salva come PNG Salva come JPEG
Categoria #
all - tutte 264.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 264.699
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.307 0 0 0 159 78 324 133 118 264 307 123 801
2022/20233.506 372 283 80 362 270 795 322 323 295 23 291 90
2023/20241.299 145 41 187 25 137 306 52 40 31 65 23 247
2024/20258.227 253 1.656 822 476 137 569 592 304 746 624 1.162 886
2025/202613.616 1.019 683 1.334 1.341 1.224 827 1.761 1.790 1.435 1.082 642 478
2026/20274.319 676 786 2.490 367 0 0 0 0 0 0 0 0
Totale 108.221